Pharmacy Investigational Drug Services for Clinical Research

Size: px
Start display at page:

Download "Pharmacy Investigational Drug Services for Clinical Research"

Transcription

1 Pharmacy Investigational Drug Services for Clinical Research Jennifer Colon, PharmD, MS, MBA Pharmacy Clinical Specialist-Investigational Drug Services Temple University Hospital Adjunct Clinical Professor-Temple University School of Pharmacy

2 Objectives Learn about services provided by Investigational Drug Services (IDS) Pharmacy Understand how using the IDS Pharmacy can assist and enhance research Gain further understanding of operations within the IDS pharmacy

3 Pharmacy Locations Inpatient Pharmacy/Pharmacy Administration/Research Pharmacy; Rock Pavilion Zone B, Basement Inpatient Pharmacy Satellite; Boyer 3 rd Floor Outpatient Cancer Center Pharmacy; 4 th Floor ACC Building Outpatient Pharmacy; 1 st Floor Parkinson s Pavilion

4 IDS Operations Pharmacy Clinical Specialist (Jen Colon) Back Up Pharmacist Regular Operations (Outpatient Studies) Monday through Friday 7:30am 4pm Inpatient Studies 24 hour service through Inpatient Pharmacy (2-8280) On call and special arrangements (Jen)

5 Investigational Drug Definition Agent being considered for commercial marketing, not yet approved by the FDA Approved medication being studied for an unlabeled use or population Investigational drugs can be: new drugs or old drugs with: new indications; new combinations; or new components; or investigational use of commercially available drugs

6 Purpose of the IDS Pharmacy To ensure research involving investigational medicine is conducted appropriately, maximizing patient safety Provide additional support to study teams related to research (randomization, drug accountability and disposition, blinding/unblinding)

7 Regulatory Compliance The IDS pharmacy assures compliance with all federal (FDA, NIH, NCI), state, JCAHO, and IRB regulations concerning investigational medication. The IDS pharmacy also assures compliance with TUHS administrative/nursing/pharmacy policies The IDS Pharmacy assures compliance with USP 797 & 795 guidelines

8 Regulations & Drug Research State of Pennsylvania Dispensing (any legend drugs, including investigational drugs) is limited to a licensed pharmacist, physician, or dentist Pharmacy practice act governs requirements for labeling, documentation of medication dispensing Investigational drugs for inpatient administration must be stored and dispensed from the hospital pharmacy

9 FDA Requirements-Investigational Drug Storage Secure location with limited access Storage conditions according to instructions on drug label or in accordance with the protocol (temperature, humidity, light, min/max temps) Investigator Responsibilities 21 CFR Administer drug only to subjects under personal supervision of primary investigator or sub-i. Access to the drug is limited and not supplied to those not authorized to receive it.

10 Joint Commission Requirements MM.7.40-Investigational medications are safely controlled and administered Pharmacy is responsible for the storage, dispensing, labeling, and distribution of investigational medications. Investigational Drug Data Sheet (IDDS) describing therapeutic indications, AEs, drugdrug interactions, and contraindications must be part of the permanent medical record

11 Investigational Drug Service Basic Activities: Registration of drug s use in hospital Procurement (ordering, returns, inventory management) Storage Preparing/packaging Dispensing Provision of drug information Maintenance of records

12 Compounding and Packaging

13 Packaging-Euclid

14 Packaging-Euclid

15 Packaging-Blister Packs

16 Investigational Drug Service Administrative Responsibilities Reordering investigational drugs* Disposal of used or unused drug in accordance with sponsor s protocol and hospital policy (TUH-ADMIN-930(1).801)* Preparing and maintaining pharmacy binders for each protocol Preparing budget proposals for pharmacy charges for each protocol Billing for IDS services *at the discretion of the primary investigator and study team

17 Investigational Drug Service Administrative Responsibilities IRB Membership at Temple University and Fox Chase Cancer Center Protocol management Staff development and in-servicing education Providing guidance related to compounding and handling of hazardous medications (biologics, chemotherapy, human tissue) Providing tours for site qualification and accommodating all site visits

18 A Quick Tour.. Temple University Hospital Inpatient Pharmacy holds some of the most advanced pharmacy technology in the region. Using these systems helps ensure patient safety and drug delivery efficacy and accuracy. Investigational drugs are stored according to CFR which mandates all investigational drugs must be stored in a securely locked, substantially constructed enclosure, with limited access to prevent theft or diversion

19 Advanced Technology-Talyst

20 Advanced Technology-Intelifil

21 Room Temperature Storage

22 Room Temperature Storage

23 Refrigerated Storage

24 Narcotic Vault

25 Narcotic Vault

26 -20 Degree Freezer

27 Sterile Compounding Room-Positive Pressure Hood

28 Sterile Compounding Room-Positive Pressure Hood

29 Cancer Center Pharmacy-Negative Pressure Hood

30 Cancer Center Pharmacy-Negative Pressure Hood

31 Cancer Center Pharmacy-Positive Pressure Hood

32 Cancer Center Pharmacy- Refrigerated Storage

33 Investigational Drug Service Research and Development Activities: Protocol development-especially drug delivery and monitoring Act as unblinded personnel in single and double blind studies (Pharmacy will break the blind if needed) Randomization (if requested) Pharmaceutical research (formulation & development) Preparation of dosage forms Drug analysis & quality control

34 IDS Pharmacy Services Initial protocol review Access pharmacy s ability to accommodate the protocol (biologic, human tissue, virus) Participate in site qualification, pre-study, monitor visits, and audits Study budgeting for drugs and pharmacy services Pharmacy procedure and IDDS (Investigational drug data sheet) development

35 IDS Pharmacy Services Store, dispense, & account for study medications from initial sponsor shipment through final drug return or destruction Support of investigator initiated projects (study design, randomization, blinding, accountability log development, preparation of double-blind drug and placebos, and patient monitoring) Maintenance of discontinued study documents

36 When is the IDS Pharmacy Required to be Involved? Pharmacy must dispense any inpatient administered investigational medication. Any medication requiring preparation or manipulation of any kind (USP 797 & 795 guidelines) for both outpatient and inpatient studies Any medication requiring repackaging or relabeling (USP 795 guidelines) Any premixed intravenous infusion administered inpatient or outpatient. Compounding of placebo match

37 Exceptions at TUHS Prepackaged oral medications (pills, inhalers) or topical agents for outpatient protocols can be stored in primary investigators department. Medication must be stored in a temperature controlled, locked area of the department with limited access.

38 What Does Pharmacy Need from the Study Team? IRB and contract approval before study can be opened for dispensing All study materials must be supplied to the pharmacy prior to initiating a study A time period of 6 weeks notice is requested to ensure staff is trained, as appropriate Ensure an IDDS sheet is provided to pharmacy and placed in each inpatient s chart

39 Initiating IDS Services Review of draft protocol or grant IDS cost proposal (usually requested by Arleen Wallen for sponsored projects as part of protocol budget) Access legal requirements and any special needs Evaluate ability to conduct study Ensure that pharmacy fees are included in research contract or grant

40 Requirements Prior to First Dispensing Drug must be onsite Final protocol and investigator s brochure (electronic copies are acceptable) Pharmacy binder or all documents needed to make one (accountability logs, destruction logs, specific temp logs) Notice of IRB approval-irb number (all studies must be approved by the IRB) Grant/study specific account numbers (FOAPAL)

41 I m Ready to Enroll a Patient.How Do I Order an Investigational Drug?

42 Required Medication Order Contents-Inpatient Order Must be entered into MIS/TDS by a physician on the study team as a non formulary type in to prevent insurance from being charged Study name and IRB number must be included in the order Active agent vs. placebo (if blinded) Drug name, dose, route, frequency of administration, quantity, or duration Order states that This drug is for investigational use only Pharmacy will provide you with a summary of how to enter an order for each study

43 Required Medication Order Contents-Outpatient Order A written order or BUMPO (Back up medication physician order) must be submitted to the IDS pharmacist prior to dispensing. Drug study name and IRB number Allergies Patient medical record number Drug name, dose, route, and frequency of administration Quantity or duration Primary investigator signature Date and time the medication is needed

44 This Sounds too Good to be Free How Much Do You Charge for IDS Services?

45 Pharmacy Charges Prior to initiation of any protocol an IDS budget estimate will be provided to the study team and the Clinical Trials Office Each protocol will be invoiced quarterly as appropriate for pharmacy services

46 Pharmacy Charges Development of Dispensing Protocol and Procedures $1,500 Patient Randomization Maintain Drug Inventories Unit-dose Oral or Topical Unit-dose Injection Intravenous Infusion Parenteral Nutrition Antineoplastic Agent Compounded or Packaged Doses Outpatient Dispensing Fee $10/patient $20/month $5/dose $10/dose $15/dose $30/dose $50/dose $40/hour $10/drug Termination of Investigational Study $500

47 How Much Notice is Needed for Site Visits? Monitoring visits/site qualification visits/closure visits-please allow 2 weeks advanced notice to ensure pharmacy can accommodate the visit.

48 Frequently Asked Questions.

49 How Do We Deal With Research that Involves Commercial Product? Sometimes commercially available drug will be supplied by the sponsor. If it is not it is ordered by pharmacy and stored separately from regular stock. We do not use regular pharmacy stock for investigational purposes All investigational drugs are stored separately from regular stock Once the study closes, the drug is destroyed.

50 Do We Mark Up the Price of Medication Acquired for Research? All medication purchased by pharmacy for investigator initiated and federally funded research (NIH, NCI) is provided to the investigator at cost. All medication purchased by pharmacy for a sponsored study is marked up by 30%

51 Why Can t We Reuse Medication Returned to the Pharmacy? Per FDA guidelines and state regulations we can not reuse medications once they are dispensed for patient safety. Storage conditions outside of the pharmacy may allow for loss of integrity. We would no longer have assurance of strength, quality, purity, or identity of the drug. The pharmacist or doctor dispensing a drug is legally responsible for all hazards or contaminations that may arise if they return dispensed drug back into regular stock

52 How Are Temperatures Monitored At TUH? Room temperature-daily manual recorded temps Investigational refrigerators-daily manual recorded temps -20 Freezer-daily electronic recording via a temperature recording disk All devices are alarmed and the manager on call and maintenance are notified if a deviation occurs

53 What is Used to Make Matching Placebo Oral? Our most common compounding procedure is to fill an empty gelatin capsule with an inert substance (lactose monohydrate or starch) We utilize an opaque capsule to maintain the blind. Our capsules come from Medisca, Inc. Placebo tablets can be manufactured by our GMP lab at the School of Pharmacy (separate entity from TUH Pharmacy)

54 How Do Blind Active Medication if it has a Matching Placebo? We ensure both active and placebo medication look (and weigh in the case of capsules) identical prior to packaging or dispensing. For an injectable agent an opaque sleeve may be placed over a bag or syringe if coloring of each agent varies The compound (active/placebo) is documented and a lot number is assigned to differentiate when packaging

55 How Do We Dispose of Investigational Medication? If the investigational drug is a proprietary agent the sponsor usually takes accountability for it upon expiration or study closure Chemotherapy is deidentified and disposed of in yellow chemo waste containers contracted to Stericycle for destruction Investigational medication is deidentified and disposed of in Red Biohazard trash also contracted to Stericycle for destruction

56 How Long are Binders and Study Records Stored? After one year of on site storage binders are compiled and sent to GRM for storage. GRM stores the binders for 25 years then they are destroyed. All study documents can be recalled from GRM within 24 to 48 hours of an investigator s request.

57 Is IRB Approval Sufficient to Activate Dispensing of Investigational Drugs? No. The study must be reviewed by pharmacy to ensure we have the capabilities to store and manipulate the investigational product This is especially relevant as we are seeing more and more biologics, stem cells, and human tissue There are complex storage & compounding capabilities not yet available: -70 freezer & Liquid Nitrogen both being installed tentatively in summer 2014 Viruses can not be manipulated in any pharmacy hoods Studies related to human tissue must be manipulated in the Cytology lab in a purified biological safety cabinet

58 Where Can I Find an IDDS Template to Fill Out? A blank copy of the IDDS template is on file with the research pharmacist. This can be provided to you via upon request. Completed copies are stored electronically and in each pharmacy binder to be placed into the patient s chart prior to the first dose of study drug being administered.

59 What are Common Errors Seen on the IDDS? Members of the study team and primary contact information incorrect or out of date. IRB number missing from the form Information regarding the excipient in placebo excluded (important if patient has a lactose allergy) Drug-drug & drug-food interactions incomplete The research pharmacist can assist you in completing this form and performs the final review

60 Things to Remember. Contact the IDS pharmacist as early as possible when anticipating a new protocol Remember to budget for IDS services Notify the IDS pharmacist about the status of each study (termination, extension, changes in protocol, etc.) Provide plenty of notice for upcoming monitor visits Provide notice regarding patient schedules and visits

61 Things to Remember Provide accurate and up to date grant/foapal numbers and IRB number Inpatient-physician on the study team must enter complete electronic orders in a timely manner Outpatient-Provide complete and signed orders in a timely manner Outsourcing of pharmacy services must be done with the knowledge and approval of the IDS

62 Future IDS Support Digital temperature monitoring devices -70 freezer being installed summer 2014 Liquid nitrogen storage being installed Summer 2014 EPIC inpatient installation Looking into Vestigo electronic IDS management (McCreadie Group) Separate research pharmacy

63 Additional Questions?

64 Contact Information Jennifer Colon, PharmD, MS, MBA Office (215) Cell (267) Pharmacy Administration-Rock Pavilion, Zone B, Basement (across from the cafeteria entrance)

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11 Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies

More information

Investigational Drugs: Investigational Drugs and Biologics

Investigational Drugs: Investigational Drugs and Biologics : I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place

More information

CONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION

CONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed

More information

ARKANSAS. Downloaded January 2011

ARKANSAS. Downloaded January 2011 ARKANSAS Downloaded January 2011 302 GENERAL ADMINISTRATION 302.11 Pharmacies operated in nursing homes shall be operated in compliance with Arkansas laws and shall be subject to inspection by personnel

More information

CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)

CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist

More information

BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS

BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS 855-041-6050 Definitions Hospitals with Pharmacies (1) In

More information

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER MEDICATIONS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED BY APPLIES

More information

UTCVM PHARMACY STANDARD OPERATING PROCEDURES

UTCVM PHARMACY STANDARD OPERATING PROCEDURES UTCVM PHARMACY STANDARD OPERATING PROCEDURES Updated: 4/5/2004 I. General Procedures A. Hours: The Pharmacy will be open Monday through Friday, 8:00AM to 6:00PM; Saturday 8:00AM to 1:00PM. The Pharmacy

More information

UW School of Dentistry Comprehensive Medication Policy

UW School of Dentistry Comprehensive Medication Policy UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides

More information

NOTE: In the event that the seal is accidentally broken, the narcotic may be wasted via narcotic wastage procedures.

NOTE: In the event that the seal is accidentally broken, the narcotic may be wasted via narcotic wastage procedures. HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER NARCOTICS AND CONTROLLED DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES

More information

11 MEDICATION MANAGEMENT

11 MEDICATION MANAGEMENT 1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,

More information

Custodial Procedures Manual Table of Contents

Custodial Procedures Manual Table of Contents Custodial Procedures Manual Table of Contents Page 1. Drug Policies and Procedures 1 A. Procurement of Prescription Drugs 1 i. Prescription drugs may only be accepted from 1 pharmacies and or practitioners.

More information

IMP management at site. Dmitry Semenyuta

IMP management at site. Dmitry Semenyuta IMP management at site Dmitry Semenyuta TOP 5 FDA inspections finding 1999-2009 Center of Drug Evaluation and Research (CDER) Failure to follow the protocol Failure to keep adequate and accurate records

More information

Complete Pharmacy Technician Certificate Program 230 clock hours

Complete Pharmacy Technician Certificate Program 230 clock hours Complete Pharmacy Technician Certificate Program 230 clock hours Course Description Our Pharmacy Technician Career Training Program will give the pharmacy technician the knowledge to achieve the competencies

More information

PREP WORKSHOP #11 Investigational Drug Disposal

PREP WORKSHOP #11 Investigational Drug Disposal PREP WORKSHOP #11 Investigational Drug Disposal Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, Clinical Research Service Miyuki Yoshida-Hay, RSO, MLSO, CHSP Safety Office,

More information

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Charlesworth Rae, BS, PharmD, JD Investigational Drug Pharmacist July 2012 1 Outline of Presentation I. Introduction

More information

GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS

GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS Prepared by Ad Hoc Committee on Nuclear Pharmacy Technicians Nuclear Pharmacy Section Academy of Pharmacy Practice and Management American Pharmaceutical

More information

PHARMACY TECHNICIAN SERIES

PHARMACY TECHNICIAN SERIES PHARMACY TECHNICIAN SERIES Occ. Work Prob. Effective Last Code No. Class Title Area Area Period Date Action 4058 Pharmacy Technician I 12 446 6 mo. 02/15/04 Revised 4059 Pharmacy Technician II 12 446 6

More information

16.19.10.11 PUBLIC HEALTH CLINICS: A. CLINIC LICENSURE: (1) All clinics where dangerous drugs are administered, distributed or dispensed shall obtain

16.19.10.11 PUBLIC HEALTH CLINICS: A. CLINIC LICENSURE: (1) All clinics where dangerous drugs are administered, distributed or dispensed shall obtain 16.19.10.11 PUBLIC HEALTH CLINICS: A. CLINIC LICENSURE: (1) All clinics where dangerous drugs are administered, distributed or dispensed shall obtain a limited drug permit as described in Section 61-11-14

More information

Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO

Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines

More information

Planning Issues for Hospital Pharmacies with Growing Outpatient Populations

Planning Issues for Hospital Pharmacies with Growing Outpatient Populations Planning Issues for Hospital Pharmacies with Growing Outpatient Populations In recent years, there has been an increasing emphasis in healthcare on the provision of ambulatory care services. It is predicted

More information

Extemporaneously Prepared Early Phase Clinical Trial Materials

Extemporaneously Prepared Early Phase Clinical Trial Materials Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development

More information

Health Professions Act BYLAWS SCHEDULE F. PART 2 Hospital Pharmacy Standards of Practice. Table of Contents

Health Professions Act BYLAWS SCHEDULE F. PART 2 Hospital Pharmacy Standards of Practice. Table of Contents Health Professions Act BYLAWS SCHEDULE F PART 2 Hospital Pharmacy Standards of Practice Table of Contents 1. Application 2. Definitions 3. Drug Distribution 4. Drug Label 5. Returned Drugs 6. Drug Transfer

More information

May 2010 Rhonda Dash, MPH Director, Research Compliance

May 2010 Rhonda Dash, MPH Director, Research Compliance May 2010 Rhonda Dash, MPH Director, Research Compliance Introduce the new Director of Research Compliance Review Applicable Federal Regulations Review Applicable State Regulations Review UNTHSC new Policies

More information

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS (By authority conferred on the director of the department of licensing and

More information

School Based Emergency Medicine Class D Clinic

School Based Emergency Medicine Class D Clinic School Based Emergency Medicine Class D Clinic NM Board of Pharmacy Policy and Procedure Manual School Based Emergency Medicine Class D Clinic REQUIRED FOR COMPLIANCE NM Board of Pharmacy Approved Policy

More information

Roles & Responsibilities of the Sponsor

Roles & Responsibilities of the Sponsor Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from

More information

The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial

The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives

More information

Nurse-Managed Medication Inventory

Nurse-Managed Medication Inventory Nurse-Managed Medication Inventory Information for Employers College of Registered Nurses of British Columbia 2855 Arbutus Street Vancouver, BC Canada V6J 3Y8 T: 604.736.7331 F: 604.738.2272 Toll-free:

More information

EDUCATOR S LESSON PLAN

EDUCATOR S LESSON PLAN EDUCATOR S LESSON PLAN Pharmacy Technician Training Program Student Version Orientation Orientation introduces the student to basic terms and definitions. An introduction to the Pharmacy Technician Certification

More information

West Los Angeles College Pharmacy Technician Program

West Los Angeles College Pharmacy Technician Program West Los Angeles College Pharmacy Technician Program I. STERILE PRODUCTS EXTERNSHIP - 2.25 Unit(s) Phrmctk 38 Section: 1632 II. PREPARED BY: Pharmacy Technician Adjunct Faculty III. REVISED FOR: Spring

More information

CHAPTER 6 OUTPATIENT SURGICAL CENTERS 6. 1

CHAPTER 6 OUTPATIENT SURGICAL CENTERS 6. 1 CHAPTER 6 OUTPATIENT SURGICAL CENTERS 6. 1 OUTPATIENT SURGICAL CENTERS I. LICENSURE 1. Modified II B Pharmacy license 2. DEA license II. REQUIREMENTS 1. Formulary may be any drugs needed to meet the medical

More information

PHARMACEUTICAL WASTE MANAGEMENT DUKE UNIVERSITY HEALTH SYSTEM

PHARMACEUTICAL WASTE MANAGEMENT DUKE UNIVERSITY HEALTH SYSTEM PHARMACEUTICAL WASTE MANAGEMENT DUKE UNIVERSITY HEALTH SYSTEM BLUE BIN DRUGS ONLY NO EMPTY Packages, NO Gloves NO Scissors, Syringes, Needles, IVs Scalpels, Forceps BLUE BIN PROGRAM PURPOSE AND OBJECTIVE:

More information

PHARMACY TECHNICIAN CERTIFICATION PREPARATION Course Syllabus

PHARMACY TECHNICIAN CERTIFICATION PREPARATION Course Syllabus 6111 E. Skelly Drive P. O. Box 477200 Tulsa, OK 74147-7200 PHARMACY TECHNICIAN CERTIFICATION PREPARATION Course Syllabus Course Number: THRP-0423 OHLAP Credit: No OCAS Code: None Course Length: 30 Hours

More information

NEWFOUNDLAND AND LABRADOR PHARMACY BOARD Standards of Pharmacy Practice. Standards for Hospital Pharmacies

NEWFOUNDLAND AND LABRADOR PHARMACY BOARD Standards of Pharmacy Practice. Standards for Hospital Pharmacies NEWFOUNDLAND AND LABRADOR PHARMACY BOARD Standards of Pharmacy Practice Standards for Hospital Pharmacies Approved by the Newfoundland and Labrador Pharmacy Board January 11, 1998 Updated: June 16, 2007

More information

GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION

GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION GUIDELINES GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION Preamble The purpose of this document is to provide guidance for the pharmacist

More information

ADMINISTRATION OF MEDICATIONS POLICY

ADMINISTRATION OF MEDICATIONS POLICY Policy 6.007. ADMINISTRATION OF MEDICATIONS POLICY It is the policy of Cooperative Educational Services (C.E.S.) that students who require any medications to be administered during school hours, including

More information

- 1 - First Time Pharmacy Managers (Revised 02/02/2011)

- 1 - First Time Pharmacy Managers (Revised 02/02/2011) State of Connecticut Department of Consumer Protection Commission of Pharmacy 165 Capitol Avenue, Room 147 Hartford, CT 06106 - Telephone: 860-713-6070 ALL FIRST-TIME PHARMACY MANAGERS ARE REQUIRED TO

More information

SafetyFirst Alert. Errors in Transcribing and Administering Medications

SafetyFirst Alert. Errors in Transcribing and Administering Medications SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2001 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical

More information

Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication

Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication POLICY SOMERSET COUNTY BOARD OF EDUCATION 1. PURPOSE Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication Number: 600-32 Date

More information

Administrative Policies and Procedures for MOH hospitals /PHC Centers. TITLE: Organization & Management Of Medication Use APPLIES TO: Hospital-wide

Administrative Policies and Procedures for MOH hospitals /PHC Centers. TITLE: Organization & Management Of Medication Use APPLIES TO: Hospital-wide Administrative Policies and Procedures for MOH hospitals /PHC Centers TITLE: Organization & Management Of Medication Use APPLIES TO: Hospital-wide NO. OF PAGES: ORIGINAL DATE: REVISION DATE : السیاسات

More information

Austin Community College Institutional Pharmacy Practice PHRA 1449 Syllabus

Austin Community College Institutional Pharmacy Practice PHRA 1449 Syllabus Austin Community College Institutional Pharmacy Practice PHRA 1449 Syllabus Instructor: Office: Office Hours: Length of Program: 16 weeks Total Number of Hours (approximate): 96 Classroom Hours: 48 Laboratory

More information

105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS

105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS 105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS Section 210.001: Purpose 210.002: Definitions 210.003: Policies Governing the Administration of Prescription

More information

Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6

Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6 Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication

More information

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011

More information

Educational Outcomes for Pharmacy Technician Programs in Canada

Educational Outcomes for Pharmacy Technician Programs in Canada Canadian Pharmacy Technician Educators Association (CPTEA) Educational Outcomes for Pharmacy Technician Programs in Canada March 2007 Educational Outcomes for Pharmacy Technician Page 1 of 14 Framework

More information

USE OF CONTROLLED SUBSTANCES AN OVERVIEW FOR RESEARCHERS

USE OF CONTROLLED SUBSTANCES AN OVERVIEW FOR RESEARCHERS USE OF CONTROLLED SUBSTANCES AN OVERVIEW FOR RESEARCHERS APPLICABILITY (WITH REGARD TO CONTROLLED SUBSTANCES) This presentation is applicable to: Animal and non-animal research This presentation is mostly

More information

03 PHARMACY TECHNICIANS

03 PHARMACY TECHNICIANS 03 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS: A. PHARMACY TECHNICIAN: This term refers to those individuals identified as Pharmacist Assistants

More information

Philosophy: Although sample medication may be helpful in patient care, drug samples:

Philosophy: Although sample medication may be helpful in patient care, drug samples: Title: Policy on Sample Medication Policy #: 450.80 Adopted: 1/90, 7/00 Revised: 3/95, 5/98, 7/00, 10/01 Reviewed: 7/00, 10/01, 02/03 This policy is applicable to the following Henry Ford Health System

More information

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015 Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the

More information

PHARMACEUTICAL MANAGEMENT PROCEDURES

PHARMACEUTICAL MANAGEMENT PROCEDURES PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription

More information

Device Accountability in Clinical Research

Device Accountability in Clinical Research Office of Human Research Device Accountability in Clinical Research Managing research device inventory & tracking Objectives Define device accountability Review the two main categories of research devices

More information

Pharmacy Technician Structured Practical Training Program Logbook

Pharmacy Technician Structured Practical Training Program Logbook Pharmacy Technician Structured Practical Training Program Logbook This logbook outlines the activities that pharmacy technician learners are required to complete in order to demonstrate competencies as

More information

CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS

CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS Overview 6.1 This chapter sets out the Review Committee s findings and recommendations on procurement

More information

IAC 10/5/11 Pharmacy[657] Ch 40, p.1 CHAPTER 40 TECH-CHECK-TECH PROGRAMS

IAC 10/5/11 Pharmacy[657] Ch 40, p.1 CHAPTER 40 TECH-CHECK-TECH PROGRAMS IAC 10/5/11 Pharmacy[657] Ch 40, p.1 CHAPTER 40 TECH-CHECK-TECH PROGRAMS 657 40.1(155A) Purpose and scope. The board may authorize a hospital pharmacy to participate in a tech-check-tech program. The board

More information

A Outpatient Services A1 AMBULATORY CARE CENTRE A1(d) Cancer Centre Clinical Trials Office

A Outpatient Services A1 AMBULATORY CARE CENTRE A1(d) Cancer Centre Clinical Trials Office A1(d) CANCER CENTRE CLINICAL TRIALS OFFICE A1(d).1 SERVICE DESCRIPTION A1(d).1.1 Scope of Clinical Services This section A1(d) sets out the requirements for the centralized facilities for the Clinical

More information

MASSACHUSETTS. Downloaded January 2011

MASSACHUSETTS. Downloaded January 2011 MASSACHUSETTS Downloaded January 2011 150.007 NURSING SERVICES (G) Nursing and Supportive Routines and Practices. (2) No medication, treatment or therapeutic diet shall be administered to a patient or

More information

RULE. The Administration of Medication in Louisiana Public Schools

RULE. The Administration of Medication in Louisiana Public Schools RULE The Administration of Medication in Louisiana Public Schools Developed in 1994 by The Louisiana State Board of Elementary and Secondary Education and The Louisiana State Board of Nursing Amendments

More information

Verbalize knowledge of laws and policies for administration of prescribed and over the counter medication to students.

Verbalize knowledge of laws and policies for administration of prescribed and over the counter medication to students. Medication Administration for Non-Licensed School Staff Canton City Schools School Health Issues: A federal mandate created in the 1970s obligated schools to provide children with medical services, including

More information

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility

More information

West Los Angeles College Pharmacy Technician Program

West Los Angeles College Pharmacy Technician Program West Los Angeles College Pharmacy Technician Program I. IN PATIENT PHARMACY EXTERNSHIP - 2.25 Unit(s) Phrmctk 36 Section: 1630 II. PREPARED BY: Pharmacy Technician Adjunct Faculty III. REVISED FOR: Spring

More information

Outpatient Prescription Drug Benefit

Outpatient Prescription Drug Benefit Outpatient Prescription Drug Benefit GENERAL INFORMATION This supplemental Evidence of Coverage and Disclosure Form is provided in addition to your Member Handbook and Health Plan Benefits and Coverage

More information

Pharmacy and Therapeutics Committee Policies and Procedures

Pharmacy and Therapeutics Committee Policies and Procedures Pharmacy and Therapeutics Committee Policies and Procedures I. Charter... p 2 II. Formulary Principles... p 3 III. Drug Review Process... p 4 7 A. When are Medications Reviewed B. How Are Medications Reviewed

More information

Policy for the Storage and Administration of Medication in Custody Suites

Policy for the Storage and Administration of Medication in Custody Suites Not Protectively Marked Policy for the Storage and Administration of Medication in Custody Suites Policy Reference No. P22:2000 Portfolio Holder Assistant Chief Constable Policy Owner Superintendent Donnell

More information

PHARMACY TECHNICIAN COURSE DESCRIPTIONS

PHARMACY TECHNICIAN COURSE DESCRIPTIONS PHARMACY TECHNICIAN COURSE DESCRIPTIONS OCCUPATIONAL COMPLETION POINTS AND PROGRAM LENGTH: * Basic Healthcare Worker OCP A 90 Hours (COURSE #HSC 0003) * Community Pharmacy Technician OCP B 360 Hours (COURSE

More information

State Regulations Pertaining to Pharmacy Services

State Regulations Pertaining to Pharmacy Services State Regulations Pertaining to Pharmacy Services Note: This document is arranged alphabetically by State. To move easily from State to State, click the Bookmark tab on the Acrobat navigation column to

More information

Safe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช

Safe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช Safe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช Chemotherapy Agent. Low therapeutic index. -Increase risk for medication error. Hazardous

More information

PHARMACEUTICAL WASTE UPDATE ON HANDLING AND DISPOSAL ASTSWMO MEETING August 11, 2011

PHARMACEUTICAL WASTE UPDATE ON HANDLING AND DISPOSAL ASTSWMO MEETING August 11, 2011 PHARMACEUTICAL WASTE UPDATE ON HANDLING AND DISPOSAL ASTSWMO MEETING August 11, 2011 Pharmaceutical Waste Getting the attention it deserves Are there Federal, State and Local laws & regulations to comply

More information

Inventory Management

Inventory Management Inventory Management Chapter Outline Inventory Management Inventory Systems Computer & Inventory Ordering Forms Stocking & Storing Inventory Management Inventory A listing of medication of the goods or

More information

Evolution of a Closed Loop Medication Use Process

Evolution of a Closed Loop Medication Use Process Evolution of a Closed Loop Medication Use Process Paul J. Vitale, Pharm.D. pvitale@mdmercy.com Vice President and Chief Pharmacy Officer The Mercy Medical Center Baltimore, Maryland Agenda Hospital Background

More information

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Legislative changes PDMP program changes 503B outsourcing facilities Rules changes Ph800 review Ph300 Ph400 Ph700 Current issues

More information

The following Good Compounding Practices (GCPs) are meant to apply only to the compounding of drugs by State-licensed pharmacies.

The following Good Compounding Practices (GCPs) are meant to apply only to the compounding of drugs by State-licensed pharmacies. 1 NABP Model State Pharmacy Act & Model Rules Appendix B Good Compounding Practices Applicable to State Licensed Pharmacies The following Good Compounding Practices (GCPs) are meant to apply only to the

More information

ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes

ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes # scored items 1. Regulations and Pharmacy Duties 35 A. Overview of technician

More information

ADMINISTRATION OF MEDICATION

ADMINISTRATION OF MEDICATION ADMINISTRATION OF MEDICATION IN SCHOOLS MARYLAND STATE SCHOOL HEALTH SERVICES GUIDELINE JANUARY 2006 (Reference Updated March 2015) Maryland State Department of Education Maryland Department of Health

More information

DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY

DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY Remote Pharmacy Owner Name: DBA Name: Address: Telephone Number: Fax Number:

More information

Guidance on the content of a pharmacy manual to support clinical trial protocols

Guidance on the content of a pharmacy manual to support clinical trial protocols Guidance on the content of a pharmacy manual to support clinical trial protocols This guidance has been produced to help investigators with the content of pharmacy manuals for clinical trials. We gratefully

More information

A Guide to Pharmacy Documentation For Clinical Trials

A Guide to Pharmacy Documentation For Clinical Trials A Guide to Pharmacy Documentation For Clinical Trials Roy Sinclair Clinical Trials Pharmacist St. George s Hospital (to Sep 2007) Lecturer Kingston University January 2008 A Guide to Pharmacy Documentation

More information

Title 16. Board of Pharmacy Proposed Text

Title 16. Board of Pharmacy Proposed Text Title 16. Board of Pharmacy Proposed Text Proposal to add new Article 9.1 of Division 17 of Title 16 of the California Code of Regulations and a new Article title as follows: Article 9.1. Prescription

More information

Health Products and Food Branch. www.hc-sc.gc.ca

Health Products and Food Branch. www.hc-sc.gc.ca Health Products and Food Branch 1 HEALTH CANADA PART C DIVISION 5 - DRUGS FOR CLINICAL TRIALS INVOLVING HUMAN SUBJECTS Part C - Division 5 2 Part A: Part B: Part C: Part D: Part E: Part G: Part J: Administration

More information

The Study Site Master File and Essential Documents

The Study Site Master File and Essential Documents The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010

More information

2013 -- H 5230 S T A T E O F R H O D E I S L A N D

2013 -- H 5230 S T A T E O F R H O D E I S L A N D ======= LC00 ======= 01 -- H 0 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO HEALTH AND SAFETY - THE RETURN OR EXCHANGE OF DRUGS ACT Introduced

More information

Ambulatory Surgical Centers Frequently Asked Questions

Ambulatory Surgical Centers Frequently Asked Questions Ambulatory Surgical Centers Frequently Asked Questions Index Top General Definitions Compliance with State Licensure Laws Governing Body and Management Surgical Services Quality Assessment and Performance

More information

How To Write A Binder Tab

How To Write A Binder Tab Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,

More information

Table of Contents. 2 P a g e

Table of Contents. 2 P a g e Table of Contents Introduction... 3 Important Contact Information... 3 Pharmacy Rights... 3 Claims Adjudication... 3 Reversals... 4 Required Data Fields... 4 Identification cards... 4 Required Identification

More information

National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment

National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient

More information

NH Laws / Rules Regarding Limited Retail Drug Distributors

NH Laws / Rules Regarding Limited Retail Drug Distributors NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant

More information

ADMINISTRATION OF MEDICATION

ADMINISTRATION OF MEDICATION SOUTH LYON COMMUITY SCHOOLS 5330/page 1 of 6 ADMINISTRATION OF MEDICATION Definitions Medication includes both prescription and non-prescription medications including those taken by mouth, inhaler, injection,

More information

Table of Contents. FACT Quality Handbook, Second Edition. Table of Contents

Table of Contents. FACT Quality Handbook, Second Edition. Table of Contents Table of Contents INTRODUCTION... i ACKNOWLEDGEMENTS... ii 1. Quality Management Program Overview... 1 Diagram of Quality Program Elements... 9 Sample Quality Management Performance Summary: Colorado Blood

More information

Medication Administration for Non-Licensed School Staff

Medication Administration for Non-Licensed School Staff Medication Administration for Non-Licensed School Staff School Health Issues A federal mandate created in the 1970s obligated schools to provide children with medical services, including medication administration.

More information

Policies and Procedures. Number: 1127

Policies and Procedures. Number: 1127 Policies and Procedures Title: NARCOTIC CONTROL: DOCUMENTATION AND COUNT Authorization: [X] Pharmacy/Nursing Committee [X] SHR Nursing Practice Committee Number: 1127 Source: Pharmacy/Nursing Cross Index:

More information

Health Care Job Information Sheet #10. Pharmacy

Health Care Job Information Sheet #10. Pharmacy Health Care Job Information Sheet #10 Pharmacy A. Occupations A. Occupations 1) Pharmacist 2) Pharmacy Technician/ Assistant B. Labour Market Prospects C. ITPs in the Field D. Links 1) Pharmacist Regulated

More information

Safe Handling of Oral Chemotherapy. Rick Abbott Regional Pharmacy Manager, Systemic Therapy Eastern Health, NL Rick.abbott@easternhealth.

Safe Handling of Oral Chemotherapy. Rick Abbott Regional Pharmacy Manager, Systemic Therapy Eastern Health, NL Rick.abbott@easternhealth. Safe Handling of Oral Chemotherapy Rick Abbott Regional Pharmacy Manager, Systemic Therapy Eastern Health, NL Rick.abbott@easternhealth.ca Conflict of Interest Declaration I have developed and delivered

More information

REGULATION 3 PHARMACY TECHNICIANS

REGULATION 3 PHARMACY TECHNICIANS REGULATION 3 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS (a) Pharmacy technician means those individuals, exclusive of pharmacy interns, who assist

More information

Pharmaceutical Wholesaler Site Inspection Checklist

Pharmaceutical Wholesaler Site Inspection Checklist Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:

More information

GUIDELINES FOR DRUG-USE CONTROL

GUIDELINES FOR DRUG-USE CONTROL GUIDELINES FOR DRUG-USE CONTROL PREFACE These guidelines were originally published by the Canadian Society of Hospital Pharmacists (CSHP) as the CSHP Standards of Practice (1993). With the revision of

More information

Purpose... 2. What s new?... 2. Role of pharmacists and pharmacy technicians in physician-assisted death... 3

Purpose... 2. What s new?... 2. Role of pharmacists and pharmacy technicians in physician-assisted death... 3 Table of Contents Purpose... 2 What s new?... 2 Role of pharmacists and pharmacy technicians in physician-assisted death... 3 Complying with ACP s Standards of Practice for Pharmacists and Pharmacy Technicians...

More information

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,

More information

Microbiology and Auditing. Don Singer

Microbiology and Auditing. Don Singer Microbiology and Auditing Don Singer ASQ Northeast Pharmaceutical GMP/Quality Conference 2011 Through the eyes of a Microbiologist Microbiology Audit = Inspection / Investigation Systematic Auditing Planning

More information

Disposal of Pharmaceuticals, and their empty containers, in the Workplace

Disposal of Pharmaceuticals, and their empty containers, in the Workplace Disposal of Pharmaceuticals, and their empty containers, in the Workplace Prepared by Bio-Team Mobile LLC There is a lot of misinformation being circulated about disposal of pharmaceuticals ever since

More information